1-1 of 1
Maki Jingu
Close
Sort by
Journal Articles

First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative

Hiroshi Azuma, Toraji Amano, Naoya Kamiyama, Naofumi Takehara, Maki Jingu, Harumi Takagi, Osamu Sugita, Naoko Kobayashi, Tomoko Kure, Taro Shimizu, Tatsuhiro Ishida, Masanori Matsumoto, Hiromi Sakai
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5711–5715.
https://doi.org/10.1182/bloodadvances.2022007977
Published: 2022
Includes: Supplemental data